FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045840367> ?p ?o ?g. }

• W2045840367 endingPage "343" @default.
• W2045840367 startingPage "334" @default.
• W2045840367 abstract "Objectives To evaluate the risk factors for lopinavir/ritonavir (LPV/r)‐related liver enzyme elevation (LEE) in HIV antiretroviral‐experienced patients. Methods An open prospective observational study was carried out to analyse the incidence and time of LEE development during LPV/r treatment, and to determine whether LEE development was correlated with epidemiological, clinical and biochemical data, immune and virological profiles, concomitant hepatic diseases, antiretroviral therapy, or histological and ultrasonography liver examination results. A diagnosis of LEE was considered when LEE symptoms occurred after LPV/r introduction and was confirmed by a second control within 2 weeks. Results A total of 782 HIV‐positive outpatients have been enrolled in six different Infectious Diseases Departments in Northern Italy since August 2000. Of these patients, 71 (9.1%) developed LEE within 115±85 days (mean±standard deviation); 13 of these subjects discontinued LPV/r and four were hospitalized. Of the patients with LEE, 74.6% and 25.4% had grade 2 and ≥3 toxicity, respectively. No correlation between LEE and sex, baseline CD4 cell count, viral load, HIV stage, triglyceride values, histological and ultrasonography liver examination results, nevirapine use, or increase in CD4 cell count was observed. Higher baseline alanine aminotransferase (ALT) and γ‐glutamyltransferase (GGT) values ( P < 0.0001 and P =0.004, respectively), younger age ( P =0.008), previous hepatitis B virus (HBV) infection ( P =0.012), efavirenz use ( P =0.04), and hepatitis C virus (HCV) and/or HBV coinfection ( P < 0.0001, relative risk 4.78) were significantly related to LEE. No correlations between LEE and the same risk factors as investigated in the whole study population were found in subgroups of patients with HCV and/or HBV infection. Conclusions HCV and HBV testing and measurement of baseline ALT values are essential for screening subjects at risk of LEE before starting LPV/r. Strict monitoring of clinical and biochemical parameters should be performed in these patients." @default.
• W2045840367 created "2016-06-24" @default.
• W2045840367 creator A5002187853 @default.
• W2045840367 creator A5028933821 @default.
• W2045840367 creator A5032588577 @default.
• W2045840367 creator A5034720988 @default.
• W2045840367 creator A5040869978 @default.
• W2045840367 creator A5044411998 @default.
• W2045840367 creator A5047570485 @default.
• W2045840367 creator A5049035721 @default.
• W2045840367 creator A5081736345 @default.
• W2045840367 creator A5082623681 @default.
• W2045840367 creator A5087143842 @default.
• W2045840367 creator A5087788423 @default.
• W2045840367 creator A5089728271 @default.
• W2045840367 date "2004-09-01" @default.
• W2045840367 modified "2023-10-16" @default.
• W2045840367 title "Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation" @default.
• W2045840367 cites W1963759393 @default.
• W2045840367 cites W1971978263 @default.
• W2045840367 cites W1978367955 @default.
• W2045840367 cites W1981900811 @default.
• W2045840367 cites W1986859702 @default.
• W2045840367 cites W1994838458 @default.
• W2045840367 cites W2008258552 @default.
• W2045840367 cites W2013907757 @default.
• W2045840367 cites W2031510386 @default.
• W2045840367 cites W2034482023 @default.
• W2045840367 cites W2052853915 @default.
• W2045840367 cites W2058379533 @default.
• W2045840367 cites W2064155400 @default.
• W2045840367 cites W2085691878 @default.
• W2045840367 cites W2106004827 @default.
• W2045840367 cites W2106762291 @default.
• W2045840367 cites W2170972537 @default.
• W2045840367 cites W2318390173 @default.
• W2045840367 cites W2326510216 @default.
• W2045840367 cites W2328211715 @default.
• W2045840367 cites W2467053533 @default.
• W2045840367 cites W4229632741 @default.
• W2045840367 cites W4230373082 @default.
• W2045840367 doi "https://doi.org/10.1111/j.1468-1293.2004.00232.x" @default.
• W2045840367 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15369508" @default.
• W2045840367 hasPublicationYear "2004" @default.
• W2045840367 type Work @default.
• W2045840367 sameAs 2045840367 @default.
• W2045840367 citedByCount "50" @default.
• W2045840367 countsByYear W20458403672012 @default.
• W2045840367 countsByYear W20458403672013 @default.
• W2045840367 countsByYear W20458403672014 @default.
• W2045840367 countsByYear W20458403672015 @default.
• W2045840367 countsByYear W20458403672016 @default.
• W2045840367 countsByYear W20458403672018 @default.
• W2045840367 countsByYear W20458403672020 @default.
• W2045840367 countsByYear W20458403672021 @default.
• W2045840367 countsByYear W20458403672022 @default.
• W2045840367 crossrefType "journal-article" @default.
• W2045840367 hasAuthorship W2045840367A5002187853 @default.
• W2045840367 hasAuthorship W2045840367A5028933821 @default.
• W2045840367 hasAuthorship W2045840367A5032588577 @default.
• W2045840367 hasAuthorship W2045840367A5034720988 @default.
• W2045840367 hasAuthorship W2045840367A5040869978 @default.
• W2045840367 hasAuthorship W2045840367A5044411998 @default.
• W2045840367 hasAuthorship W2045840367A5047570485 @default.
• W2045840367 hasAuthorship W2045840367A5049035721 @default.
• W2045840367 hasAuthorship W2045840367A5081736345 @default.
• W2045840367 hasAuthorship W2045840367A5082623681 @default.
• W2045840367 hasAuthorship W2045840367A5087143842 @default.
• W2045840367 hasAuthorship W2045840367A5087788423 @default.
• W2045840367 hasAuthorship W2045840367A5089728271 @default.
• W2045840367 hasConcept C120665830 @default.
• W2045840367 hasConcept C121332964 @default.
• W2045840367 hasConcept C126322002 @default.
• W2045840367 hasConcept C142462285 @default.
• W2045840367 hasConcept C203014093 @default.
• W2045840367 hasConcept C2777182164 @default.
• W2045840367 hasConcept C2777382497 @default.
• W2045840367 hasConcept C2777813720 @default.
• W2045840367 hasConcept C2779130552 @default.
• W2045840367 hasConcept C2779298103 @default.
• W2045840367 hasConcept C2781432083 @default.
• W2045840367 hasConcept C2993143319 @default.
• W2045840367 hasConcept C3013748606 @default.
• W2045840367 hasConcept C61511704 @default.
• W2045840367 hasConcept C71924100 @default.
• W2045840367 hasConcept C90924648 @default.
• W2045840367 hasConceptScore W2045840367C120665830 @default.
• W2045840367 hasConceptScore W2045840367C121332964 @default.
• W2045840367 hasConceptScore W2045840367C126322002 @default.
• W2045840367 hasConceptScore W2045840367C142462285 @default.
• W2045840367 hasConceptScore W2045840367C203014093 @default.
• W2045840367 hasConceptScore W2045840367C2777182164 @default.
• W2045840367 hasConceptScore W2045840367C2777382497 @default.
• W2045840367 hasConceptScore W2045840367C2777813720 @default.
• W2045840367 hasConceptScore W2045840367C2779130552 @default.
• W2045840367 hasConceptScore W2045840367C2779298103 @default.
• W2045840367 hasConceptScore W2045840367C2781432083 @default.
• W2045840367 hasConceptScore W2045840367C2993143319 @default.

• next